Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

David E. Nix, William A. Watson, Michelle E. Lener, R. Wayne Frost, George Krol, Harvey Goldstein, John Lettieri, Jerome J. Schentag

Research output: Contribution to journalArticle

148 Citations (Scopus)

Abstract

The effect of an antacid (Maalox) and ranitidine administration on the absorption of ciprofloxacin was evaluated in healthy male volunteers who were enrolled in three separate studies. Each study was designed as a three- or four-period crossover and included the administration of 750 mg ciprofloxacin alone as a control treatment. Treatments that were evaluated included the administration of ciprofloxacin 5 to 10 minutes, 2 hours, 4 hours, and 6 hours after a single 30 ml dose of antacid; the administration of antacid 2 hours after ciprofloxacin was given; and the administration of ciprofloxacin 2 hours after a 200 mg ranitidine tablet. Administration of antacid within 4 hours before ciprofloxacin dose resulted in a significant decrease in ciprofloxacin absorption (p < 0.05). Percentages of relative bioavailability compared with control values were 15.1%, 23.2%, and 70% for the 5 to 10 minute, 2 hour, and 4 hour antacid pretreatments, respectively. Administration of antacid 6 hours before or 2 hours after the ciprofloxacin dose did not affect absorption. Ranitidine did not alter ciprofloxacin absorption. Antacids that contain magnesium and aluminum salts may reduce the absorption of ciprofloxacin. The extent of this interaction appears to increase as the time between administration of the two drugs decreases. Ranitidine is suggested as an alternative to antacids for patients receiving treatment with ciprofloxacin.

Original languageEnglish (US)
Pages (from-to)700-705
Number of pages6
JournalClinical Pharmacology and Therapeutics
Volume46
Issue number6
StatePublished - Dec 1989
Externally publishedYes

Fingerprint

Antacids
Ranitidine
Ciprofloxacin
Aluminum
Magnesium
Biological Availability
Tablets
Healthy Volunteers
Therapeutics
Salts

ASJC Scopus subject areas

  • Pharmacology

Cite this

Nix, D. E., Watson, W. A., Lener, M. E., Wayne Frost, R., Krol, G., Goldstein, H., ... Schentag, J. J. (1989). Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clinical Pharmacology and Therapeutics, 46(6), 700-705.

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. / Nix, David E.; Watson, William A.; Lener, Michelle E.; Wayne Frost, R.; Krol, George; Goldstein, Harvey; Lettieri, John; Schentag, Jerome J.

In: Clinical Pharmacology and Therapeutics, Vol. 46, No. 6, 12.1989, p. 700-705.

Research output: Contribution to journalArticle

Nix, DE, Watson, WA, Lener, ME, Wayne Frost, R, Krol, G, Goldstein, H, Lettieri, J & Schentag, JJ 1989, 'Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin', Clinical Pharmacology and Therapeutics, vol. 46, no. 6, pp. 700-705.
Nix DE, Watson WA, Lener ME, Wayne Frost R, Krol G, Goldstein H et al. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clinical Pharmacology and Therapeutics. 1989 Dec;46(6):700-705.
Nix, David E. ; Watson, William A. ; Lener, Michelle E. ; Wayne Frost, R. ; Krol, George ; Goldstein, Harvey ; Lettieri, John ; Schentag, Jerome J. / Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. In: Clinical Pharmacology and Therapeutics. 1989 ; Vol. 46, No. 6. pp. 700-705.
@article{860ef7dd827f4d999171405a1a4e4b94,
title = "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin",
abstract = "The effect of an antacid (Maalox) and ranitidine administration on the absorption of ciprofloxacin was evaluated in healthy male volunteers who were enrolled in three separate studies. Each study was designed as a three- or four-period crossover and included the administration of 750 mg ciprofloxacin alone as a control treatment. Treatments that were evaluated included the administration of ciprofloxacin 5 to 10 minutes, 2 hours, 4 hours, and 6 hours after a single 30 ml dose of antacid; the administration of antacid 2 hours after ciprofloxacin was given; and the administration of ciprofloxacin 2 hours after a 200 mg ranitidine tablet. Administration of antacid within 4 hours before ciprofloxacin dose resulted in a significant decrease in ciprofloxacin absorption (p < 0.05). Percentages of relative bioavailability compared with control values were 15.1{\%}, 23.2{\%}, and 70{\%} for the 5 to 10 minute, 2 hour, and 4 hour antacid pretreatments, respectively. Administration of antacid 6 hours before or 2 hours after the ciprofloxacin dose did not affect absorption. Ranitidine did not alter ciprofloxacin absorption. Antacids that contain magnesium and aluminum salts may reduce the absorption of ciprofloxacin. The extent of this interaction appears to increase as the time between administration of the two drugs decreases. Ranitidine is suggested as an alternative to antacids for patients receiving treatment with ciprofloxacin.",
author = "Nix, {David E.} and Watson, {William A.} and Lener, {Michelle E.} and {Wayne Frost}, R. and George Krol and Harvey Goldstein and John Lettieri and Schentag, {Jerome J.}",
year = "1989",
month = "12",
language = "English (US)",
volume = "46",
pages = "700--705",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

AU - Nix, David E.

AU - Watson, William A.

AU - Lener, Michelle E.

AU - Wayne Frost, R.

AU - Krol, George

AU - Goldstein, Harvey

AU - Lettieri, John

AU - Schentag, Jerome J.

PY - 1989/12

Y1 - 1989/12

N2 - The effect of an antacid (Maalox) and ranitidine administration on the absorption of ciprofloxacin was evaluated in healthy male volunteers who were enrolled in three separate studies. Each study was designed as a three- or four-period crossover and included the administration of 750 mg ciprofloxacin alone as a control treatment. Treatments that were evaluated included the administration of ciprofloxacin 5 to 10 minutes, 2 hours, 4 hours, and 6 hours after a single 30 ml dose of antacid; the administration of antacid 2 hours after ciprofloxacin was given; and the administration of ciprofloxacin 2 hours after a 200 mg ranitidine tablet. Administration of antacid within 4 hours before ciprofloxacin dose resulted in a significant decrease in ciprofloxacin absorption (p < 0.05). Percentages of relative bioavailability compared with control values were 15.1%, 23.2%, and 70% for the 5 to 10 minute, 2 hour, and 4 hour antacid pretreatments, respectively. Administration of antacid 6 hours before or 2 hours after the ciprofloxacin dose did not affect absorption. Ranitidine did not alter ciprofloxacin absorption. Antacids that contain magnesium and aluminum salts may reduce the absorption of ciprofloxacin. The extent of this interaction appears to increase as the time between administration of the two drugs decreases. Ranitidine is suggested as an alternative to antacids for patients receiving treatment with ciprofloxacin.

AB - The effect of an antacid (Maalox) and ranitidine administration on the absorption of ciprofloxacin was evaluated in healthy male volunteers who were enrolled in three separate studies. Each study was designed as a three- or four-period crossover and included the administration of 750 mg ciprofloxacin alone as a control treatment. Treatments that were evaluated included the administration of ciprofloxacin 5 to 10 minutes, 2 hours, 4 hours, and 6 hours after a single 30 ml dose of antacid; the administration of antacid 2 hours after ciprofloxacin was given; and the administration of ciprofloxacin 2 hours after a 200 mg ranitidine tablet. Administration of antacid within 4 hours before ciprofloxacin dose resulted in a significant decrease in ciprofloxacin absorption (p < 0.05). Percentages of relative bioavailability compared with control values were 15.1%, 23.2%, and 70% for the 5 to 10 minute, 2 hour, and 4 hour antacid pretreatments, respectively. Administration of antacid 6 hours before or 2 hours after the ciprofloxacin dose did not affect absorption. Ranitidine did not alter ciprofloxacin absorption. Antacids that contain magnesium and aluminum salts may reduce the absorption of ciprofloxacin. The extent of this interaction appears to increase as the time between administration of the two drugs decreases. Ranitidine is suggested as an alternative to antacids for patients receiving treatment with ciprofloxacin.

UR - http://www.scopus.com/inward/record.url?scp=0024807149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024807149&partnerID=8YFLogxK

M3 - Article

C2 - 2598571

AN - SCOPUS:0024807149

VL - 46

SP - 700

EP - 705

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -